XML 51 R27.htm IDEA: XBRL DOCUMENT
v3.22.1

LOSS PER SHARE | 12 Months Ended
--- | ---
Dec. 31, 2021
Loss Per Share | 22. LOSS PER SHARE The following securities were not included in the computation of diluted shares outstanding because the effect would be anti-dilutive as the Company has a net loss for each period presented:
Thousands of securities |  | December 31, 2021 |  |  | December 31, 2020 |
Stock options (Note 17) |  |  | 5,448 |  |  |  | 3,794 |
Warrants (Note 18) |  |  | 8,746 |  |  |  | 9,000 |
Total anti-dilutive |  |  | 14,194 |  |  |  | 12,794 |
In February 2022, as part of the Company’s acquisition of JustCBD (Note 26), the Company issued 9.5 million common shares as part of the purchase consideration. See additional Company common share and stock option transactions in 2022 at Note 26.

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 33 -IssueDate 2021-01-01 -Section Disclosure -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=33&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS33_g70-73A_TI -URIDate 2021-03-24 + Details
Name: | ifrs-full_DisclosureOfEarningsPerShareExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration